All In MedTech

Device Trial Radar · NCT07876115

Cross-Over Study Evaluating the TASKA GEN2 Myoelectric Hand Prosthesis

Prospective Multicentre Randomized Cross-Over Study Evaluating Specific Function of Upper-Limb Amputee Patients Using the Multi-Grip Myoelectric Hand Prosthesis GEN2 Versus Other Multi-Grip Myoelectric Hand Prostheses

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jun 13, 2025

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
TASKA ProstheticsNot on our public-company list
Sponsor type
Industry
First posted
Oct 15, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective multicentre randomized cross-over post-market clinical follow-up study compares the TASKA GEN2 multi-grip myoelectric hand prosthesis with marketed comparator prostheses in adults with upper-limb amputation. The study evaluates specific function using the Patient-Specific Functional Scale together with upper-limb function, comfort, quality of life, satisfaction and safety outcomes.

Conditions

  • Upper Limb Amputation
  • Transradial Amputation
  • Transhumeral Amputation

Interventions

  • TASKA GEN2 Multi-Grip Myoelectric Hand ProsthesisDevice

    Participants use the Taska Gen2 multi-grip myoelectric prosthesis

  • Michelangelo or I-Limb Ultra multi-grip myoelectric prosthesisDevice

    Participants use their usual marketed multi-grip myoelectric hand prosthesis (Michelangelo or I-Limb Ultra) during the relevant 28-day study period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Patient-Specific Functional Scale (PSFS).Time frame: End of each 28-day wearing period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Multiple facilities

    Multiple Locations, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.